tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Progyny downgraded to Neutral from Buy at BTIG

BTIG downgraded Progyny to Neutral from Buy without a price target following the Q2 report. Despite the “decent” quarter, management reduced 2024 revenue and EBITDA guidance for the second quarter in a row, visibility seems low, and risk remains in 2025, the analyst tells investors in a research note. The firm believes Progyny’s lower expected membership could be due to a weakening consumer, worries over the election cycle, worries related to the recent Alabama Supreme Court ruling, and companies reducing labor costs. The risk is high that Progyny experiences a sustained slowdown in growth, contends BTIG.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1